Search
Showing results for "1"
Research
Hypersensitivity: ImmunologicalThis comprehensive review provides an introduction to immunological hypersensitivity, discusses the sensitisation of T-cell lineages.
Research
Adverse obstetric and perinatal outcomes following treatment of adolescent and young adult cancer: A population-based cohort studyFemale survivors of AYA cancer have moderate excess risks of adverse obstetric and perinatal outcomes arising from subsequent pregnancies
Research
Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodiesWe compared risk of newly detected infection and cervical abnormalities associated with HPV-16/18 between seronegative vs seropositive women (15-25 years) in...
Research
Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: A longitudinal population-based studyTo investigate the single and combined effectiveness of commonly prescribed secondary preventive medications (post-acute myocardial infarction (AMI)) in...
To coordinate and monitor clinical trial sites with the aim of meeting protocol and good clinical practice requirements.
The Wesfarmers Centre has established the Deborah Lehmann Research Award to acknowledge the significant contribution that Clinical Associate Professor Deborah Lehmann AO has made to paediatric infectious disease research.
Diagnosis and early life risk factors for bronchiectasis in cystic fibrosis: a review ABSTRACT Introduction: Lung disease in cystic fibrosis begins
Research
Respiratory impedance and bronchodilator responsiveness in healthy children aged 2-13 yearsThere is limited information on changes in FOT outcomes in healthy children beyond the preschool years and the level of bronchodilator responsiveness (BDR)...
Research
A modular approach to forecasting COVID-19 hospital bed occupancyMonitoring the number of COVID-19 patients in hospital beds was a critical component of Australia's real-time surveillance strategy for the disease. From 2021 to 2023, we produced short-term forecasts of bed occupancy to support public health decision-making.